Skip to main content
. 2022 Jun 2;24:132. doi: 10.1186/s13075-022-02826-6

Table 6.

Linear regression using as dependent variable the number of serious adverse events in the cohort

Predictor Beta 95% confidence interval p value
Gender 0.163  − 0.151 to 0.477 0.308
Age  − 0.003  − 0.014 to 0.009 0.651
RCDI 0.033  − 0.029 to 0.095 0.294
Number of concomitant non-biologics  − 0.108  − 0.291 to − 0.075 0.246
 ≥ 2 previous non-biologics (yes) 0.320 0.013 to 0.627 0.041
 ≥ 2 of previous biologics (yes)  − 0.096  − 0.331 to 0.140 0.425
Low dose (yes) 0.003  − 0.276 to 0.274 0.995
Prednisolone > 5 mg/day for at least 2 FUs in cohort 0.689 0.373 to 1.006  < 0.0001
Past hospitalization for serious infection (yes) 0.974 0.690 to 1.259  < 0.0001

F-statistic 9.823; p < 0.0001 on 9 degrees of freedom, n = 350 included in the analysis